Sequential versus concomitant therapy for treatment of Helicobacter pylori infection: an updated systematic review and meta-analysis Youhua WangRulin ZhaoYong Xie Review 08 October 2017 Pages: 1 - 13
Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis Wu Yi ZhengL. C. RichardsonM. T. Baysari Review 23 October 2017 Pages: 15 - 27
Effects of rosuvastatin and atorvastatin on nonsustained ventricular tachycardia in patients with ST-elevation myocardial infarction: a retrospective analysis Xianqing HuJian ChengChunjian Li Clinical Trial 30 September 2017 Pages: 29 - 35
Effect of breviscapine on CYP3A metabolic activity in healthy volunteers Xuan ZhouYang-yang GaoYong Lai Clinical Trial 06 October 2017 Pages: 37 - 44
Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin Takahiro SuzukiTakuma KagamiTakahisa Furuta Pharmacodynamics 06 October 2017 Pages: 45 - 52
CYP3A genotypes of donors but not those of the patients increase the risk of acute rejection in renal transplant recipients on calcineurin inhibitors: a pilot study Guillermo GervasiniGuadalupe García-PinoEnrique Luna Pharmacogenetics 18 October 2017 Pages: 53 - 60
Effects of food and grapefruit juice on single-dose pharmacokinetics of blonanserin in healthy Chinese subjects De-Wei ShangZhan-Zhang WangYu-Guan Wen Pharmacokinetics and Disposition 03 October 2017 Pages: 61 - 67
A randomized phase I study to evaluate the safety, tolerability, pharmacokinetics and food-effect of Iguratimod in healthy adult volunteers Feng XiaoFeng ZhangWei Wei Pharmacokinetics and Disposition 19 October 2017 Pages: 69 - 77
Population pharmacokinetics of treosulfan and development of a limited sampling strategy in children prior to hematopoietic stem cell transplantation Dorota DanielakJadwiga TwardoszFranciszek Główka Pharmacokinetics and Disposition Open access 03 October 2017 Pages: 79 - 89
The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects Satish Kumar BedadaPrasad Neerati Pharmacokinetics and Disposition 05 October 2017 Pages: 91 - 97
Tamoxifen usage correlates with increased risk of Parkinson’s disease in older women with breast cancer: a case–control study in Taiwan Hsien-Feng LinKuan-Fu LiaoShih-Wei Lai Pharmacoepidemiology and Prescription 01 October 2017 Pages: 99 - 107
Health status and drug use 1 year before and 1 year after skilled nursing home admission during the first quarter of 2013 in France: a study based on the French National Health Insurance Information System Alice AtramontDominique Bonnet-ZamponiPhilippe Tuppin Pharmacoepidemiology and Prescription 03 October 2017 Pages: 109 - 118
Antidepressants and the risk of arrhythmia in elderly affected by a previous cardiovascular disease: a real-life investigation from Italy A. BiffiF. Reaon behalf of the Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE) Pharmacoepidemiology and Prescription 18 October 2017 Pages: 119 - 129
Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee’s list of recommended essential medicines (the ‘Wise List’) Jaran EriksenMarie-Louise OvesjöPia Bastholm-Rahmner Pharmacoepidemiology and Prescription Open access 23 October 2017 Pages: 131 - 138
Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin Reinier SmitRob J. van MarumHieronymus J. Derijks Letter to the Editor 27 September 2017 Pages: 139 - 140
No, we are not—we keep forgetting the right ventricle Victoria C. ZiesenitzWalter E. HaefeliMatthias Gorenflo Letter to the Editor 13 October 2017 Pages: 141 - 143
Authors reply to “No, we are not—we keep forgetting the right ventricle” Luxitaa GoenkaMelvin GeorgeSandhiya Selvarajan Letter to the Editor 10 October 2017 Pages: 145 - 146